Literature DB >> 28986742

Treatment strategies for central low-grade chondrosarcoma of long bones: a systematic review of the literature and meta-analysis.

S S Shemesh1, J D Acevedo-Nieves1, J Pretell-Mazzini2.   

Abstract

The need for wide local excision (WLE) versus intralesional (IL) treatment of low-grade chondrosarcomas (CS) of the appendicular skeleton remains controversial. We sought to perform a systematic review and meta-analysis to compare different conventional types of surgical treatments for grade I CS in terms of: (1) rate of local recurrence (LR) and metastases, (2) functional outcome as measured by the Musculoskeletal Tumor Society (MSTS) score, (3) complication rate. Eighteen studies enrolling 695 patients met our criteria. Studies reported on WLE versus IL treatment (n = 7), and IL treatment with or without different adjuvants (N = 11). The LR rate was not significantly different between WLE and IL treatment (OR 2.31; 95% CI, 0.85-6.2; P = 0.1). On the contrary, complication rates were significantly lower in favor of IL treatment (OR 2.27; 95% CI, 0.07-0.72; P = 0.012). The mean reported MSTS score ranged from 21.8 to 28.2 for WLE and from 26.5 to 29.7 for IL treatment, with a significant difference in favor of IL treatment. IL treatment as an alternative to WLE does not greatly increase the risk of LR or metastasis and has lower complication rates with better functional scores. In light of the retrospective nature of the studies available, our findings should be interpreted with caution.

Entities:  

Keywords:  Adjuvant; Intralesional treatment; Low-grade chondrosarcoma; Recurrence; Wide local excision

Mesh:

Substances:

Year:  2017        PMID: 28986742     DOI: 10.1007/s12306-017-0507-7

Source DB:  PubMed          Journal:  Musculoskelet Surg        ISSN: 2035-5114


  53 in total

Review 1.  What are the levels of evidence on which we base decisions for surgical management of lower extremity bone tumors?

Authors:  Nathan Evaniew; James Nuttall; Forough Farrokhyar; Mohit Bhandari; Michelle Ghert
Journal:  Clin Orthop Relat Res       Date:  2013-10-01       Impact factor: 4.176

2.  Chondrosarcoma of bone: lessons from 46 operated cases in a single institution.

Authors:  Olavo Pires de Camargo; André Mathias Baptista; Marcelo Junqueira Atanásio; Daniel Reis Waisberg
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

3.  Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading.

Authors:  H L Evans; A G Ayala; M M Romsdahl
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

4.  Curettage and cryosurgery for low-grade cartilage tumors is associated with low recurrence and high function.

Authors:  David G Mohler; Richard Chiu; David A McCall; Raffi S Avedian
Journal:  Clin Orthop Relat Res       Date:  2010-06-24       Impact factor: 4.176

5.  [The PRISMA statement extension for systematic reviews incorporating network meta-analysis: PRISMA-NMA].

Authors:  Brian Hutton; Ferrán Catalá-López; David Moher
Journal:  Med Clin (Barc)       Date:  2016-03-31       Impact factor: 1.725

Review 6.  A systematic review and meta-analysis of intralesional versus wide resection for intramedullary grade I chondrosarcoma of the extremities.

Authors:  Michael Hickey; Forough Farrokhyar; Ben Deheshi; Robert Turcotte; Michelle Ghert
Journal:  Ann Surg Oncol       Date:  2011-01-22       Impact factor: 5.344

7.  Low-grade chondrosarcoma of long bones treated with intralesional curettage followed by application of phenol, ethanol, and bone-grafting.

Authors:  Suzan H M Verdegaal; Hugo F G Brouwers; Erik W van Zwet; Pancras C W Hogendoorn; Antonie H M Taminiau
Journal:  J Bone Joint Surg Am       Date:  2012-07-03       Impact factor: 5.284

8.  Extended intralesional treatment versus resection of low-grade chondrosarcomas.

Authors:  Chad Aarons; Benjamin K Potter; Sheila C Adams; J David Pitcher; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2009-01-14       Impact factor: 4.176

9.  How safe is curettage of low-grade cartilaginous neoplasms diagnosed by imaging with or without pre-operative needle biopsy?

Authors:  M T Brown; P D Gikas; J S Bhamra; J A Skinner; W J S Aston; R C Pollock; A Saifuddin; T W R Briggs
Journal:  Bone Joint J       Date:  2014-08       Impact factor: 5.082

10.  Surgical treatment of central grade 1 chondrosarcoma of the appendicular skeleton.

Authors:  Domenico Andrea Campanacci; Guido Scoccianti; Alessandro Franchi; Giuliana Roselli; Giovanni Beltrami; Massimiliano Ippolito; Giuseppe Caff; Filippo Frenos; Rodolfo Capanna
Journal:  J Orthop Traumatol       Date:  2013-03-06
View more
  6 in total

1.  The influence of site on the incidence and diagnosis of solitary central cartilage tumours of the femur. A 21st century perspective.

Authors:  A M Davies; A Patel; C Azzopardi; S L James; R Botchu; L Jeys
Journal:  J Clin Orthop Trauma       Date:  2022-07-30

2.  CCN6-mediated MMP-9 activation enhances metastatic potential of human chondrosarcoma.

Authors:  Huey-En Tzeng; Chih-Hsin Tang; Sz-Hua Wu; Hsien-Te Chen; Yi-Chin Fong; Yung-Chang Lu; Wei-Cheng Chen; Hsien-Da Huang; Chih-Yang Lin; Shih-Wei Wang
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

3.  Sphingosine-1-phosphate promotes PDGF-dependent endothelial progenitor cell angiogenesis in human chondrosarcoma cells.

Authors:  Chao-Qun Wang; Chih-Yang Lin; Yuan-Li Huang; Shih-Wei Wang; Yan Wang; Bi-Fei Huang; Yu-Wei Lai; Shun-Long Weng; Yi-Chin Fong; Chih-Hsin Tang; Zhong Lv
Journal:  Aging (Albany NY)       Date:  2019-12-06       Impact factor: 5.682

4.  Calcium acts as a central player in melatonin antitumor activity in sarcoma cells.

Authors:  Ana M Sánchez-Sánchez; María Turos-Cabal; Noelia Puente-Moncada; Federico Herrera; Carmen Rodríguez; Vanesa Martín
Journal:  Cell Oncol (Dordr)       Date:  2022-05-02       Impact factor: 7.051

5.  Limb Salvage Surgery With Mega-Prosthesis in a Case of Chondrosarcoma: A Case Report.

Authors:  Ankur Salwan; Gajanan L Pisulkar; Shounak Taywade; Vivek H Jadawala; Amit Saoji
Journal:  Cureus       Date:  2022-08-26

6.  Thirty-Day Outcomes after Surgery for Primary Sarcomas of the Extremities: An Analysis of the NSQIP Database.

Authors:  Kathryn E Gallaway; Junho Ahn; Alexandra K Callan
Journal:  J Oncol       Date:  2020-01-13       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.